Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00502_DB00564_nanopub.RAGLgTimqKobkRcKUSxxGZ_Y_xlB0scTed9KWYPseAnOw#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00502_DB00564 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00502_DB00564 label "DDI between Haloperidol and Carbamazepine - Carbamazepine may decrease the serum concentration of haloperidol by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of haloperidol if carbamazepine is initiated, discontinued or dose changed. [drugbank_resource:DB00502_DB00564]" assertion.
- drugbank_resource:DB00502_DB00564 identifier "drugbank_resource:DB00502_DB00564" assertion.
- drugbank_resource:DB00502_DB00564 title "DDI between Haloperidol and Carbamazepine - Carbamazepine may decrease the serum concentration of haloperidol by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of haloperidol if carbamazepine is initiated, discontinued or dose changed." assertion.
- drugbank:DB00502 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00502_DB00564 assertion.
- drugbank:DB00564 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00502_DB00564 assertion.